October 25, 2016 8:11 AM ET


Company Overview of Ardent Pharmaceuticals, Inc.

Executive Profile

James M. Hinson Jr., M.D.

Chief Medical Officer and Senior Vice President for Clinical Development, Ardent Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 3 different industries.

See Board Relationships


Mr. James M. Hinson Jr., Jim PhD, MD has been the Chief Medical Officer and Consultant of Aldagen, Inc. (known as StemCo Biomedical, Inc.) since July, 2009. Dr. Hinson serves as a Director of Regulatory Affairs at Pharmaceutical Product Development, Inc. Dr. Hinson also serves as Senior Vice President for Clinical Development and Chief Medical Officer at Ardent Pharmaceuticals, Inc. Since 2000, he has been the owner and principal of Unicorn Pharma Consulting, a pharmaceutical ...

Corporate Headquarters

631 United Drive
Durham, North Carolina 27713

United States

Phone: 919-806-1806
Fax: 919-806-1161

Board Members Memberships

There is no Board Members Memberships data available.


Vanderbilt University
Bachelor's Degree
University of Missouri-Columbia
University of Missouri-Columbia
Vanderbilt University School of Medicine

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Ardent Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.